Form 4: P3 Health Partners Director Thomas Price Acquires Stock Options

Director Thomas Price of P3 Health Partners Inc. (PIII) was granted stock options for 482,640 shares at an exercise price of $0.5461 on June 6, 2024, according to a Form 4 filing.

Summary

• Thomas Edmunds Price, a director of P3 Health Partners Inc. (PIII), filed a Form 4 with the SEC.
• The filing reports the grant of stock options to Price on June 6, 2024.
• Price acquired options to purchase 482,640 shares of Class A Common Stock at an exercise price of $0.5461 per share.
• The options vest on the earlier of June 6, 2025, or the date of the next annual meeting of the Issuer's stockholders, contingent upon continued service.
• Following the transaction, Price directly owns options for 482,640 shares.
• A Power of Attorney was executed in July 2021, authorizing individuals to act on Price's behalf for SEC filings.

Sentiment

Score: 6

Explanation: The document is a neutral regulatory filing. The stock option grant is a positive incentive for the director, but it doesn't necessarily indicate a strong positive or negative outlook for the company.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions, common in publicly traded companies. It provides transparency regarding the compensation and equity ownership of company directors.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation in the healthcare industry, used to align management's interests with shareholder value.
• The vesting schedule of one year is fairly standard, incentivizing continued service.
• Comparable companies like Oak Street Health (OSH) and Alignment Healthcare (ALHC) also utilize stock options as part of their executive compensation packages.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive incentive for the director to work towards increasing shareholder value.
• The grant has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates